Racial disparity in eosinophilic esophagitis from a single, defined population

Chatham, Daniel; Cavender, Cary P.; Lieberman, Jay

doi:10.1016/j.anai.2014.07.018

Cited by 11 publications

(8 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2 A Minnesota investigation found the prevalence to be 5.6:10,000. [1][2][3][4][5][6][7] We found that EoE occurs 2.1 times more frequently in men than in women. [2][3][4]7 We observed that disease is more frequently diagnosed in adults (86%) than in children (14%).…”

Section: To the Editormentioning

confidence: 59%

“…5, 6 We report a higher proportion of diseased children from racial minority backgrounds compared with adults (P < .0001). However, recent studies have shown increased frequency in nonwhite populations.…”

Section: To the Editormentioning

confidence: 66%

“…[1][2][3][4]6,7 However, no population-based study has been conducted to evaluate EoE epidemiology using a validated cohort, representative of the community it serves. [1][2][3][4]6,7 However, no population-based study has been conducted to evaluate EoE epidemiology using a validated cohort, representative of the community it serves.…”

Section: To the Editormentioning

confidence: 99%

See 2 more Smart Citations

Prevalence of eosinophilic esophagitis in a population-based cohort from Southern California

Kim¹,

Kim²,

Sheikh³

2015

The Journal of Allergy and Clinical Immunology: In Practice

View full text Add to dashboard Cite

Section: To the Editormentioning

confidence: 59%

Section: To the Editormentioning

confidence: 66%

See 1 more Smart Citation

Prevalence of eosinophilic esophagitis in a population-based cohort from Southern California

Kim¹,

Kim²,

Sheikh³

2015

The Journal of Allergy and Clinical Immunology: In Practice

View full text Add to dashboard Cite

“…There are no studies in the south of the country or in the South American continent. This justifies a more thorough investigation in a region of southern Brazil, the Alto Vale do Itajaí-SC, composed of 28 municipalities, with a population estimated at 300,000 inhabitants, populated predominantly by European descendants, who are epidemiologically more affected by this pathology [28].…”

Section: Introductionmentioning

confidence: 99%

Endoscopic Classification of Esophagic Eosinophilia

Fey¹,

Kotze²,

Serapião³

2018

JPP

View full text Add to dashboard Cite

Introduction: EoE (eosinophilic esophagitis) is an inflammatory condition characterized by a dense eosinophilic infiltrate in the esophageal epithelium. In Brazil, it remains a poorly diagnosed disease due to the lack of interaction between the clinician, the endoscopist, and the pathologist. The diagnosis is performed by histological study of esophageal biopsies, with at least fifteen eosinophils per high-power field (EOS/HPF). Some doubts remain with respect to patients with a clinical picture and symptoms compatible with the disease (EoE), but who have a lower number of eosinophils than established. The main objective of this study was to create an endoscopic classification for EsEo (esophageal eosinophilia), which pointed the way to the endoscopist towards the diagnosis. Methods: This study was a prospective, two-year study, at a gastrointestinal endoscopy center where all patients with endoscopic symptoms and/or endoscopic findings suggestive of EsEo were biopsied for histological examination of EOS/HPF. After the study and compilation of the results, a retrospective study was performed, based on a review of electronic medical records, where the same diagnosis was searched, although at a period when this classification was not adopted. Results: A total of 4,251 endoscopies were performed between September 2011 and September 2013. Two biopsies were performed, aimed at lesions, in 133 patients with clinical picture or imaging suggestive of EsEo. Eosinophils were found in 55 patients, corresponding to an incidence of 1.29% of the total population studied and 41.35% of the suspected cases of the disease. EoE was diagnosed in 24 patients during the period of this study. In the two-year retrospective study, only two cases of EoE were found. Conclusions: The results of this study demonstrate that the endoscopic standardization of esophageal lesions, suggestive of eosinophilia, in this case by classification, alerts the endoscopist for the diagnosis of EoE, prompting him to perform targeted biopsies. Further, it was observed that two samples of esophageal tissue were sufficient for the diagnosis. The relationship between the clinical picture, endoscopy, and histology was not evident in this study.

show abstract

“…Therefore, we felt that a more thorough investigation into this disorder is warranted, and focused on inhabitants of South Brazil, as this area is predominantly settled by Europeans descendants who are epidemiologically more prone to Ee [28].…”

mentioning

confidence: 99%

A Novel Therapy of Eosinophilic Esophagitis-Treatment of Eosinophilic Esophagitis Using a Single Dose of Intramuscular Corticosteroid and Proton Pump Inhibitor

Fey¹,

Kotze²,

Serapião³

2017

JPP

View full text Add to dashboard Cite

Background: Ee (Eosinophilic esophagitis) is an inflammatory condition characterized by a dense eosinophilic infiltrate in the esophageal epithelium. Its pathophysiology mimics that of allergic esophagitis, and evolves clinically as a chronic disease with periods of exacerbation. Symptoms and endoscopic findings are usually non-specific and similar to those of other esophageal illnesses. The mainstay of treatment of Ee is with corticosteroids and/or specific diets, which have been shown to cause symptom remission and histological improvement. Aim: The objective of this study was to demonstrate the efficacy of a novel and promising treatment protocol for Ee. Materials and methods: We prospectively evaluated 24 patients with Ee over two years. Patients were treated with a single intramuscular injection of betamethasone sodium phosphate associated with betamethasone dipropionate and a PPI (proton pump inhibitor) (rabeprazole 20 mg PO). After 4 weeks of treatment, patients underwent endoscopy and biopsy. We evaluated patients' clinical response as well as the results of endoscopic and histological examinations. Results: After 4 weeks of treatment, all patients (100%) are reported significant clinical improvement, which was corroborated by the findings on endoscopy and histology. There were no complications or adverse reactions. Conclusions: In this cohort of patients with eosinophilic esophagitis, treatment with a single intramuscular dose of corticosteroids led to complete remission of symptoms and improvement in endoscopic and histological findings.

show abstract

Racial disparity in eosinophilic esophagitis from a single, defined population

Cited by 11 publications

References 7 publications

Prevalence of eosinophilic esophagitis in a population-based cohort from Southern California

Prevalence of eosinophilic esophagitis in a population-based cohort from Southern California

Endoscopic Classification of Esophagic Eosinophilia

A Novel Therapy of Eosinophilic Esophagitis-Treatment of Eosinophilic Esophagitis Using a Single Dose of Intramuscular Corticosteroid and Proton Pump Inhibitor

Contact Info

Product

Resources

About